Medaviate

Dr. Ganesh Jadhav

Experience: 30+ years

Education: MBBS, DMRT, MD, DNB, MNAMS, FAGE, FICRO, Fellow of the Commonwealth University (UK), Fellow of the UICC

Spcialisation: Radiation Oncologist

Department: Radiation Oncology

Registration: DMC 22842 

Hospital: Indraprastha Apollo Hospital

INTRODUCTION:

Dr. Ganesh Jadhav, a radiation oncologist based in Delhi, boasts over three decades of expertise in oncology, distinguishing himself as a leading authority in radiation therapy within South Delhi. Affiliated with Apollo Hospitals, he specializes in treating various tumors, genitourinary malignancies, and breast cancer, employing advanced techniques such as intensity-modulated radiotherapy (IMRT), stereotactic radiotherapy (SRT), brachytherapy, image-guided radiotherapy (IGRT), and cranial cyber-knife radiosurgery. With a profound understanding of radiation oncology, he plays a pivotal role in devising tailored treatment plans, considering numerous factors to ensure optimal outcomes.

He may recommend external beam radiation therapy, which precisely targets cancerous growths without bodily contact, or internal radiation therapy, involving the insertion of liquid or solid radiation sources within the body. He has a compassionate approach, which underscores his commitment to alleviating patient suffering while striving for effective cures.

His extensive qualifications include MBBS, DMRT, MD, DNB, MNAMS, FAGE, FICRO, Fellow of Commonwealth University (UK), and Fellow of UICC. At Indraprastha Apollo Hospitals, he extends a comprehensive range of services, addressing a wide spectrum of radiation oncology conditions, including but not limited to colon cancer, lung cancer, throat cancer, cervical cancer, bladder cancer, brain tumors, and cancer pain management.

Work Experience

  • Consultant at Apollo Hospital.

Memberships

  • Life member of AROI (Association of Radiation Oncologists of India).
  • SNO (Society of NeuroOncology, Canada).
  • UICC Fellowship.
  • Commonwealth Fellowship to the UK.
  • Member of American Society of Therapeutic Radiation Oncology.